End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.49 CNY | -0.35% | -1.79% | -18.68% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's profit outlook over the next few years is a strong asset.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-18.68% | 812M | - | ||
+2.39% | 39.49B | B- | ||
-24.85% | 20.65B | B- | ||
-22.35% | 12.08B | B- | ||
-0.57% | 10.52B | A- | ||
-16.37% | 9.4B | B+ | ||
+39.45% | 9.35B | C+ | ||
+4.20% | 6.5B | C+ | ||
-34.53% | 4.96B | C | ||
-21.80% | 3.69B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 301216 Stock
- Ratings Wankai New Materials Co., Ltd.